Standardised prevalence and incidence of amyotrophic lateral sclerosis in urban China in 2016 (units: /100 000 person-years)
| Standardised prevalence (95% CI) | Standardised incidence (95% CI) | |
| Standardised by 2010 Chinese census data | ||
| Male | 3.53 (3.44 to 3.63) | 1.81 (1.74 to 1.88) |
| Female | 2.37 (2.29 to 2.45) | 1.23 (1.17 to 1.29) |
| Total | 2.97 (2.91 to 3.03) | 1.62 (1.58 to 1.67) |
| Standardised by RESP 2013 population census data | ||
| Male | 4.17 (4.07 to 4.28) | 2.10 (2.02 to 2.17) |
| Female | 2.62 (2.53 to 2.70) | 1.32 (1.26 to 1.39) |
| Total | 3.41 (3.34 to 3.48) | 1.84 (1.79 to 1.89) |
| Standardised by 2010 US population census data | ||
| Male | 3.86 (3.76 to 3.96) | 1.96 (1.89 to 2.03) |
| Female | 2.49 (2.41 to 2.57) | 1.27 (1.21 to 1.33) |
| Total | 3.19 (3.12 to 3.25) | 1.73 (1.68 to 1.78) |
| Standardised by 2011 Australian population census data | ||
| Male | 3.89 (3.79 to 3.99) | 1.97 (1.90 to 2.05) |
| Female | 2.50 (2.42 to 2.59) | 1.28 (1.22 to 1.34) |
| Total | 3.21 (3.14 to 3.28) | 1.74 (1.69 to 1.79) |
RESP, Revised European Standard Population.